Order Careers Contact Us Sign in Adaptive Biotechnologies Order Careers
Contact Us Sign in Immune Profiling Platform Platform OverviewPublications
Products & Services LIFE SCIENCES RESEARCHimmunoSEQ®CLINICAL
DIAGNOSTICSclonoSEQ®PipelineDRUG DISCOVERYCellular TherapyVaccines
PARTNERSHIPS Cancer Cellular TherapyAntigen MapBiopharma PartnershipsStrategic
Collaborators About Us Our StoryCultureCareersNewsroomContact Us About Us
Newsroom Press News Features Events Contact Media Relations TOP PRESS RELEASES
01/04/2019 Adaptive Biotechnologies to Enter Into Worldwide Collaboration and
License Agreement with Genentech to Develop Personalized Cellular Therapies
for the Treatment of Cancer 01/03/2019 Adaptive Biotechnologies to Present at
the 37th Annual J.P. Morgan Healthcare Conference 09/28/2018 FDA Grants De
Novo Designation for Adaptive Biotechnologies’ clonoSEQ Assay to Detect and
Monitor Minimal Residual Disease (MRD) in Patients with Multiple Myeloma and
Acute Lymphoblastic Leukemia LATEST PRESS RELEASES 06/03/2013 ASCO
Presentation Shows Sequenta’s LymphoSIGHT Technology is Highly Predictive of
Survival in Multiple Myeloma Patients 05/08/2013 Adaptive Signs Biomarker
Discovery Collaboration Agreement with Bristol-Myers Squibb 04/12/2013
Adaptive CEO Robins speaks at Xconomy’s Biotech Conference 04/05/2013 Adaptive
featured in Nature magazine 04/01/2013 Adaptive featured in Nature
Biotechnology 03/28/2013 Clinical Relevance of Minimal Residual Disease in
NEJM 03/04/2013 Adaptive Announces Young Investigator Award Recipients for
February 02/25/2013 Adaptive scientists develop “virtual flow cytometry” – a
new approach to distinguish CD4+ from CD8+ T cells using only high-throughput
sequencing on the immunoSEQ platform. 02/22/2013 Adaptive welcomes new board
member Dr. Robert Hershberg, founder and CEO of VentiRx Pharmaceuticals
Previous 1 … 11 12 13 … 15 Next TOP NEWS FEATURES 01/04/2019 Genentech: A New
Age for Neoantigens 01/03/2019 Microsoft Blog: Every immune system has a story
to tell; the key is knowing how to listen 05/09/2018 T Cell Receptor
Sequencing IDs Aggressive Lymphoma Subtype LATEST NEWS FEATURES TOP EVENTS
01/03/2019 J.P. Morgan Healthcare Conference 2019 12/01/2018 ASH 2018 LATEST
EVENTS Contact media relations phone (917) 912-7195 email
media@adaptivebiotech.com Corporate/Research (855) 466-8667 Diagnostics (888)
522-8988 Immune Profiling PlatformPlatform Overview Publications Products &
ServicesLIFE SCIENCES RESEARCH immunoSEQ® CLINICAL DIAGNOSTICS clonoSEQ®
Pipeline DRUG DISCOVERY Cellular Therapy Vaccines PartnershipsCancer Cellular
Therapy Antigen Map Biopharma Partnerships Strategic Collaborators About UsOur
Story Culture Careers News & Events Contact Us © Adaptive Biotechnologies. All
Rights Reserved. Terms of Use Online Privacy Policy Privacy Shield Policy
HIPAA Policy Code of Conduct Patents & Trademarks Licenses